Cannabis Science Inc (fka CBIS)

[joaopaulo]

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS), a US biotech company developing pharmaceutical cannabis products, is pleased to provide investor guidance on its previously announced Medicinal Cannabis Commercialization negotiations and current operational structures. Currently, Cannabis Science has some outstanding business opportunities in the final stages of closing. It anticipates announcing the first one within the next week. Some of these new deals are designed to bring its anti-cancer cannabis formulations and its other critical ailment formulations to the public through the FDA in the USA and more rapidly through other expanded markets around the world.